Drugs / Standard Dose Inactivated Influenza Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01654224 Comparator | Nov 2011 → Jun 2014 | influenza | University of Pittsburgh | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Standard Dose Inactivated Influenza Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01654224 ↗ |
| Known as | SDIV | “For SDIV, 0.5 ml of standard dose inactivated influenza vaccine consisting of a total of 45 mcg (15 mcg of each strain) of influenza virus hemagglutinin” NCT01654224 ↗ |
| Modality | Vaccine | “standard dose inactivated influenza vaccine” NCT01654224 ↗ |